US 11040039
Treatment of inflammatory disorders
granted A61KA61K31/136A61K31/423
Quick answer
US patent 11040039 (Treatment of inflammatory disorders) held by Aldeyra Therapeutics, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/136, A61K31/423, A61K31/428, A61K31/47